When during the year should seasonal influenza vaccination be discontinued?

When to Stop Offering Influenza Vaccination

Influenza vaccination should continue through June 30 and should never be stopped earlier in the year, as long as unexpired vaccine is available and influenza viruses are circulating. 1, 2

Core Recommendation: No Early Cutoff Date

The Advisory Committee on Immunization Practices (ACIP) explicitly states that vaccination should continue to be offered as long as influenza viruses are circulating and unexpired vaccine is available. 1 This is not a suggestion—it is a firm directive to avoid missed vaccination opportunities that cannot be recovered later in the season.

• All U.S.-licensed influenza vaccines expire on June 30 each year, making this the only appropriate endpoint for offering the current season's vaccine formulation. 2
• Providers should offer vaccination during routine health care visits and hospitalizations throughout the entire influenza season, including after community influenza activity has already begun. 1

Why Continuing Through June 30 Matters for Patient Outcomes

Unpredictable Timing of Peak Activity

In 58% of influenza seasons from 1982-2018, peak activity occurred in February or later, and in 42% of seasons the peak was specifically in February. 1 This means stopping vaccination in January or early February would leave patients unprotected during peak transmission.

• Influenza activity can extend into late spring (May or later) with multiple peaks within a single season. 2
• Historical surveillance data (1976-2008) shows that the season's peak fell in March in 30% of years, April in 25% of years, and May in 20% of years. 2
• Localized outbreaks indicating seasonal influenza activity can occur as early as October, but the duration and timing vary unpredictably by community. 1

Late Vaccination Remains Protective

Vaccine administered in December or later, even if influenza activity has already begun, is likely beneficial in the majority of influenza seasons. 1, 2 This directly contradicts any rationale for stopping vaccination early.

• Adults develop protective antibody levels within approximately two weeks after vaccination, so doses given late in the season still confer meaningful protection. 2
• Even individuals who have already experienced influenza during the current season should be offered vaccination because it may protect against other circulating strains. 1, 2
• Vaccine effectiveness, while it may wane at approximately 7% per month for certain strains, remains greater than zero for at least 5-6 months after administration. 1, 2

Critical Pitfalls of Stopping Early

Arbitrarily ending vaccine offers before June 30 creates irreversible missed opportunities—patients who are turned away will not return, and late seasonal peaks cannot be predicted. 2 This directly increases morbidity and mortality.

• Stopping vaccination early based on assumptions that "the season is over" is clinically unsafe because substantial influenza activity frequently occurs after March or April. 2
• Deferring or refusing vaccination to patients presenting in late winter or spring deprives them of continued protection for the remainder of the season. 2
• One study found that vaccination after mid-November was associated with higher hospitalization rates and increased all-cause mortality (RR=1.78), but this reflects suboptimal timing of initiation, not a rationale to stop offering vaccine—the solution is earlier start, not earlier cessation. 3

Practical Implementation Algorithm

1. Begin offering influenza vaccine as soon as it becomes available (typically August/September), with a goal of vaccinating most patients by the end of October. 1

2. For children aged 6 months through 8 years requiring 2 doses, start the first dose immediately upon vaccine availability to allow the second dose (≥4 weeks later) to be completed by end of October. 1

3. Continue offering vaccination at every clinical encounter through the entire influenza season—do not stop in January, February, March, April, or May. 1, 2

4. The only appropriate endpoint is June 30, when the current formulation expires and the next season's vaccine should be awaited. 2

5. Offer vaccination even after documented influenza activity in the community, as protection against circulating strains remains beneficial. 1

Special Considerations

Vaccination efforts should be structured to optimize coverage before influenza activity begins, but this does not mean stopping efforts once activity is detected. 1 The goal is maximizing population protection throughout the unpredictable season duration.

• No recommendation exists for revaccination (booster doses) later in the season for persons already fully vaccinated. 1
• Organized vaccination campaigns should continue throughout the influenza season, balancing persistence of vaccine-induced protection with avoiding missed opportunities. 1
• For nursing homes and long-term care facilities, while avoiding very early vaccination (July/August) may be prudent due to waning immunity concerns in older adults, this does not justify stopping vaccination early—continue through June 30. 1